Current Size: 100%

Publications

Below you find  a list of some of the most relevant publications from the Stoiber-Sakaguchi research team. For a complete list of publications by Dr. Dagmar Stoiber-Sakaguchi please follow this link.

 

Mizutani T, Neugebauer N, Putz EM, Moritz N, Simma O, Zebedin-Brandl E,  Gotthardt D, Warsch W, Eckelhart E, Kantner HP, Kalinke U, Lienenklaus S, Weiss S, Strobl B, Müller M, Sexl V & Stoiber D. Conditional IFNAR1 ablation reveals distinct requirements of type IFN signaling for NK cell maturation and tumor surveillance. OncoImmunology, 1:1027-37. (2012)

Musteanu M, Blaas L, Zenz R, Hoffmann T, Grabner B, Schramek D, Kantner HP, Mueller M, Kolbe T, Rülicke T, Moriggl R, Kenner L, Stoiber D, Penninger J, Popper H, Casanova E & Eferl R. A Multi-Hit mouse model to identify cooperating Ras effector pathways in lung cancer, Nature Methods, 9:897-900. (2012)

Schuster C, Berger A, Hoelzl MA, Putz EM, Frenzel A, Simma O, Moritz N, Hoelbl A, Kovacic B, Freissmuth M, Müller M, Villunger A, Müllauer L., Schmatz AI, Streubel B, Porpaczy E, Jäger U, Stoiber D* & Sexl V*. The cooperating mutation or “second hit” determines the immunological visibility towards Myc-induced lymphomas. Blood, 118:4635-45. (2011)  *Equally contributed

Fuka G, Kantner HP, Grausenburger R, Inthal A, Bauer E, Krapf G, Kaindl U, Kauer M, Dworzak MN, Stoiber D, Haas OA & Panzer-Grümayer R. Silencing of ETV6/RUNX1 abrogates PI3K/Akt/mTOR signaling and impairs reconstitution of leukemia in xenografts. Leukemia, 26:927-33 (2011)

Simma O, Zebedin E, Neugebauer N, Schellack C, Pilz A, Chang-Rodriguez S, Lingnau K, Weisz E, Felzmann T, Müller M, Decker T, Sexl V & D. Stoiber. Identification of an indispensable role for Tyk2 in CTL-mediated tumor surveillance. Cancer Res. 69:203-11. (2009)

Research Groups: